American Gene Technologies International
Rockville
About American Gene Technologies International
American Gene Technologies (AGT) is focused on creating long-term value for patients, society, investors and donors by developing and testing cutting-edge gene therapies to cure some of humanity’s worst diseases. AGT’s HIV cure clinical trial could not only lead to a blockbuster drug that brings relief to one of society's most elusive epidemics, but it could prove the efficiency and effectiveness of AGT’s platform technologies to cure dozens of diseases ranging from viruses to cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $23.2M
- Funding stage: Late Stage Venture
- Last round: Series F (Aug 2024)
- Website: americangene.com
- Phone: 301-337-2100
Industries & Categories
Biotechnology, Genetics, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/american-gene-technologies-international-62246 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.